MENU

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

PROFILE OF DRUG ABUSERS
(Facility Based)
CY 2011

AGE : Mean age of 29 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single 51.94%
STATUS OF EMPLOYMENT : Unemployed 35.16%
EDUCATIONAL ATTAINMENT : College Level 30.23%
ECONOMIC STATUS : Average Monthly Family Income Php 15,818.10
PLACE OF RESIDENCE : Urban (Specifically NCR 48.42%)
DURATION OF DRUG - TAKING : More than six (6) years
NATURE OF DRUG - TAKING : Poly drug use**
DRUGS/SUBSTANCES OF ABUSE :
                                         Methamphetamine Hydrochloride (Shabu)
                                         Cannabis (Marijuana)
                                         Inhalants (Contact Cement Adhesive)

*Residential and Out-Patient Facilities
**Poly drug users - abuse of more than one (1) drug

REPORTED CASES BY GENDER
(Facility Based)*
CY 2011

                                                   MALE                FEMALE         GRAND TOTAL
TYPE OF ADMISSION No. % No. % No. %
NEW ADMISSION 2,148  70.66  246  8.09  2,394  78.75 
RE-ADMISSION  410 13.49  15  0.49  425  13.98 
OUT-PATIENT  190  6.25  31  1.02  221  7.27 
TOTAL  2,748  90.39  292  9.61  3,040  100.00 

* Total Reported Cases from Residential and Out-Patient Facilities

DRUG ABUSE TREND: 2011 ANALYSIS

       For the year 2011, thirty (30) residential treatment and three (3) outpatient facilities reported to the Integrated Drug Abuse Data and Information Network (IDADIN). These facilities reported a total admission of 3,040 drug cases. Of this number, 78.75% or 2,394 were new admission, 13.98% or 425 were relapse cases and 7.27% or 221 were referrals from outpatient facilities.

       A 10.75% increase was recorded from previous year. The increase may be attributable to the intensified advocacy program done by the government to convince families that those who have drug problems need to undergo treatment and rehabilitation. On the other hand, the increase on the arrests of users based on the intensified operations conducted by the law enforcement on pushers/users
may also have contributed to the increase of admission in the treatment and rehabilitation facilities

* Reported Cases from Residential and Out-Patient Facilities

 
MOST COMMONLY USED/ABUSED DRUGS/SUBSTANCES
(Facility Based)*
CY 2011
DRUGS USED / ABUSED NEW ADMISSION RE-ADMISSION OUT-PATIENT GRAND TOTAL % based on the total number of responses (3,692) % based on the total number of admissions (3,040)
1. Methamphetamine Hydrochloride(Shabu) 1,812 380 116 2,308 62.51 75.92
2. Cannabis (Marijuana) 767 136 89 992 26.87 32.63
3. Inhalants (Contact Cement, Adhesive) 156 10 9 175 4.74 5.76
4. Benzodiazepines (Diazepam) 41 14 3 58 1.57 1.91
5. Cocaine 37 13   50 1.35 1.64
6. Solvent 16   15 31 0.84 1.02
7. Nalbuphine Hydrochloride (Nubain) 25 3   28 0.76 0.92
8. MDMA (Ecstasy) 18 9   27 0.73 0.89

*  Reported Cases from Residential and Out-Patient Facilities